- CLINICAL BRIEFINGS
Non-viral, precisely engineered immune cells tested in lymphoma
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-022-02272-z
Figure 1 is published under a CC BY 4.0 licence.
References
Papageorgiou, S. G., Thomopoulos, T. P., Liaskas, A. & Vassilakopoulos, T. P. Cancers 14, 1917 (2022).
Zhao, H. et al. Front. Med. 14, 711–725 (2020).
Gauthier, J. et al. Blood 139, 3722–3731 (2022).
Michieletto, D., Lusic, M., Marenduzzo, D. & Orlandini, E. Nature Commun. 10, 575 (2019).
Gándara, C., Affleck, V. & Stoll, E. A. Hum. Gene Ther. Methods 29, 1–15 (2018).